Xingwang Sun

1.4k total citations · 1 hit paper
24 papers, 1.1k citations indexed

About

Xingwang Sun is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Xingwang Sun has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Xingwang Sun's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Xingwang Sun is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (5 papers) and Cancer-related gene regulation (4 papers). Xingwang Sun collaborates with scholars based in China, United States and Thailand. Xingwang Sun's co-authors include Yuanxue Zhang, Jie Tian, Zhenhua Hu, Yue Chen, Sanjiv S. Gambhir, Chongwei Chi, Caiguang Cao, Song Su, Meishan Cai and Xiaojing Shi and has published in prestigious journals such as PLoS ONE, Scientific Reports and Clinica Chimica Acta.

In The Last Decade

Xingwang Sun

23 papers receiving 1.1k citations

Hit Papers

First-in-human liver-tumour surgery guided by multispectr... 2019 2026 2021 2023 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xingwang Sun China 9 702 422 317 163 121 24 1.1k
Tiejun Zhou China 10 694 1.0× 421 1.0× 282 0.9× 173 1.1× 105 0.9× 26 1.1k
Pan He China 11 827 1.2× 443 1.0× 174 0.5× 214 1.3× 55 0.5× 20 1.2k
Summer L. Gibbs United States 19 780 1.1× 310 0.7× 419 1.3× 263 1.6× 98 0.8× 74 1.5k
Liyang Cui China 18 671 1.0× 270 0.6× 289 0.9× 241 1.5× 59 0.5× 33 1.1k
Hua Shi China 16 549 0.8× 235 0.6× 240 0.8× 186 1.1× 77 0.6× 25 989
James M. Kaiser United States 13 514 0.7× 264 0.6× 464 1.5× 119 0.7× 66 0.5× 18 1.2k
Xinhui Su China 23 414 0.6× 234 0.6× 408 1.3× 192 1.2× 188 1.6× 76 1.3k
Meike L. Schipper Germany 14 755 1.1× 521 1.2× 294 0.9× 135 0.8× 32 0.3× 20 1.4k
Qimeng Quan China 17 476 0.7× 432 1.0× 455 1.4× 111 0.7× 81 0.7× 24 1.5k
Nutte Teraphongphom United States 13 731 1.0× 233 0.6× 159 0.5× 273 1.7× 50 0.4× 25 1.1k

Countries citing papers authored by Xingwang Sun

Since Specialization
Citations

This map shows the geographic impact of Xingwang Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xingwang Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xingwang Sun more than expected).

Fields of papers citing papers by Xingwang Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xingwang Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xingwang Sun. The network helps show where Xingwang Sun may publish in the future.

Co-authorship network of co-authors of Xingwang Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Xingwang Sun. A scholar is included among the top collaborators of Xingwang Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xingwang Sun. Xingwang Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Liu, Yun, et al.. (2023). Silencing MARCH2 Inhibits the Invasion, Migration, and EMT Transformation of Human Colorectal Cancer SW480 Cells. Technology in Cancer Research & Treatment. 22. 2223906775–2223906775. 3 indexed citations
4.
Mou, Xiao, et al.. (2023). ADORA2A promotes proliferation and inhibits apoptosis through PI3K/AKT pathway activation in colorectal carcinoma. Scientific Reports. 13(1). 19477–19477. 4 indexed citations
6.
Sun, Xingwang, et al.. (2023). Non-endoscopic Screening for Esophageal Squamous Cell Carcinoma: Recent Advances. Journal of Gastrointestinal Cancer. 55(1). 118–128. 5 indexed citations
7.
Wen, Xue, et al.. (2022). Long noncoding RNA CLAN promotes lymphangiogenesis in the colorectal carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 481(6). 847–852. 1 indexed citations
8.
Li, Fanghua, Peng Ye, Peiling Cai, et al.. (2022). Prevalence of targeted therapy-related genetic variations in NSCLC and their relationship with clinicopathological characteristics. PLoS ONE. 17(1). e0262822–e0262822. 2 indexed citations
9.
Xu, Duo, et al.. (2022). C5aR1 promotes the progression of colorectal cancer by EMT and activating Wnt/β-catenin pathway. Clinical & Translational Oncology. 25(2). 440–446. 15 indexed citations
10.
Makeudom, Anupong, et al.. (2021). Overexpression of methyltransferase‐like 3 and 14 in oral squamous cell carcinoma. Journal of Oral Pathology and Medicine. 51(2). 134–145. 14 indexed citations
11.
Chen, Yonghong, et al.. (2021). High-Expression of Cytoplasmic Poly (A) Binding Protein 1 (PABPC1) as a Prognostic Biomarker for Early-Stage Esophageal Squamous Cell Carcinoma. Cancer Management and Research. Volume 13. 5361–5372. 8 indexed citations
12.
Hu, Jiajia, et al.. (2021). Clinical and Prognostic Implications of 1p/19q, IDH, BRAF, MGMT Promoter, and TERT Promoter Alterations, and Expression of Ki-67 and p53 in Human Gliomas. Cancer Management and Research. Volume 13. 8755–8765. 10 indexed citations
13.
14.
Hu, Zhenhua, Cheng Fang, Bo Li, et al.. (2019). First-in-human liver-tumour surgery guided by multispectral fluorescence imaging in the visible and near-infrared-I/II windows. Nature Biomedical Engineering. 4(3). 259–271. 871 indexed citations breakdown →
15.
Mao, Liang, Xue Li, Yu Jiang, et al.. (2018). Serum exosomes contain ECRG4 mRNA that suppresses tumor growth via inhibition of genes involved in inflammation, cell proliferation, and angiogenesis. Cancer Gene Therapy. 25(9-10). 248–259. 67 indexed citations
17.
18.
Li, Shining, et al.. (2013). Polymorphisms of Survivin and Its Protein Expression Are Associated with Colorectal Cancer Susceptibility in Chinese Population. DNA and Cell Biology. 32(5). 236–242. 20 indexed citations
19.
Fan, Yu, Xu Zhang, Zhihui Yang, et al.. (2013). The Polymorphisms of Osteopontin Gene and Plasma Osteopontin Protein Levels with Susceptibility to Colorectal Carcinoma. DNA and Cell Biology. 32(10). 594–600. 16 indexed citations
20.
Yang, Zhihui, et al.. (2012). MMP-9 polymorphisms are related to serum lipids levels but not associated with colorectal cancer susceptibility in Chinese population. Molecular Biology Reports. 39(10). 9399–9404. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026